Les hypo-lipidémiants : Des propriétés nouvelles au fil des années, les statines et les fibrates révèlent de nouvelles propriétés. Dans le domaine de l'hta, de nouvelles études s'attachent plus précisément à en cerner les conséquences = Antilipemic agentHAÏAT, Robert.Concours médical (Paris). 2001, Vol 123, Num 10, pp 24-26, issn 0010-5309, SUPConference Paper

Mode d'action moléculaire des fibrates = Molecular mechanism of action of fibratesFRUCHART, J.-C; DURIEZ, P; STAELS, B et al.Journal de la Société de biologie. 1999, Vol 193, Num 1, pp 67-75, issn 1295-0661Article

Fenofibrate-induced photosensitivityLEENUTAPHONG, V; MANUSKIATTI, W.Journal of the American Academy of Dermatology. 1996, Vol 35, Num 5, pp 775-777, issn 0190-9622, 1Article

Pharmacokinetic interactions between statins and fibratesCORSINI, Alberto; BELLOSTA, Stefano; DAVIDSON, Michael H et al.The American journal of cardiology. 2005, Vol 96, Num 9A, pp 44K-49K, issn 0002-9149, SUPConference Paper

Differential associations of statin and fibrate treatment with carotid arterial remodelingCHIRONI, Gilles; SIMON, Alain; GARIEPY, Jérome et al.American journal of hypertension. 2005, Vol 18, Num 11, pp 1476-1481, issn 0895-7061, 6 p.Article

Rhabdomyolyse induite par le fénofibrate en monothérapie = Rhabdomyolysis induced by fenofibrate monotherapyARCHAMBEAUD-MOUVEROUX, F; LOPEZ, S; COMBES, C et al.La Revue de médecine interne (Paris). 2006, Vol 27, Num 7, pp 573-574, issn 0248-8663, 2 p.Article

Les anticholestérolémiants, nouvelles approches thérapeutiques = Anti-cholesterol agents, new therapeutic approachesFRUCHART, J.-C; DURIEZ, P.Annales pharmaceutiques françaises. 2004, Vol 62, Num 1, pp 3-18, issn 0003-4509, 16 p.Article

A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in ratsISHIHARA, Kenji; KATSUTANI, Naruo; AOKI, Toyohiko et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 99, Num 3, pp 251-260, issn 1742-7835, 10 p.Article

Study of the liquid chromatography retention of some fibrate-type antihyperlipidemic drugs on C18 and CN columns : Application for quantitation in pharmaceutical formulationsMISZTAL, Genowefa; KOMSTA, Łukasz.Journal of AOAC International. 2005, Vol 88, Num 2, pp 479-489, issn 1060-3271, 11 p.Article

Studies on the reactivity of clofibryl-S-acyl-CoA thioester with glutathione in vitroGRILLO, Mark P; BENET, Leslie Z.Drug metabolism and disposition. 2002, Vol 30, Num 1, pp 55-62, issn 0090-9556Article

Gynecomastia associated with fenofibrateGARDETTE, Virginie; VEZZOSI, Delphine; MAIZA, Jean-Christophe et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 3, pp 508-511, issn 1060-0280, 4 p.Article

Safety considerations with fibrate therapy. CommentaryDAVIDSON, Michael H; ARMANI, Annemarie; MCKENNEY, James M et al.The American journal of cardiology. 2007, Vol 99, Num 6A, issn 0002-9149, 3C-21C, SUPArticle

Simultaneously measuring concentrations of a model drug and a model excipient in solution using ultrasonic spectrometryCHEN, Raymond R; ZELESKY, Todd; ILASI, Nicholas et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 2, pp 239-247, issn 0731-7085, 9 p.Article

Self-micellization of gemfibrozil 1-O-β acyl glucuronide in aqueous solutionSHACKLEFORD, David M; PRANKERD, Richard J; SCANLON, Martin J et al.Pharmaceutical research. 2003, Vol 20, Num 3, pp 465-470, issn 0724-8741, 6 p.Article

Fenofibrate-induced cirrhosisAHMED, Furqaan; PETROVIC, Lydia; ROSEN, Ellen et al.Digestive diseases and sciences. 2005, Vol 50, Num 2, pp 312-313, issn 0163-2116, 2 p.Article

Gemfibrozil metabolite inhibits in vitro low-density lipoprotein (LDL) oxidation and diminishes cytotoxicity induced by oxidized LDLKAWAMURA, M; MIYAZAKI, S; TERAMOTO, T et al.Metabolism, clinical and experimental. 2000, Vol 49, Num 4, pp 479-485, issn 0026-0495Article

Effects of ethyl-CPIB (clofibrate) on tissue lipoprotein lipase and plasma post-heparin lipolytic activity in ratsODONKOR, J. M; PERENNA ROGERS, M.Biochemical pharmacology. 1984, Vol 33, Num 8, pp 1337-1341, issn 0006-2952Article

Syndrome musculaire aigu secondaire à la prise de fibrates = Acute muscular syndrome secondary to fibrates intakeCHAUVIN, M; KLEIN, J. M; ZUPAN, M et al.Journal de médecine de Strasbourg. 1988, Vol 19, Num 6, pp 299-300, issn 0021-7905Article

Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gammaOLIVEIRA, Antonio Carlos P; BERTOLLO, Caryne M; ROCHA, Leonardo Tadeu S et al.European journal of pharmacology. 2007, Vol 561, Num 1-3, pp 194-201, issn 0014-2999, 8 p.Article

The role of fibrates in the prevention of cardiovascular disease : a pooled meta-analysis of long-term randomized placebo-controlled clinical trialsAJOY SAHA, Sandeep; KIZHAKEPUNNUR, Lenney G; BAHEKAR, Amol et al.The American heart journal. 2007, Vol 154, Num 5, pp 943-953, issn 0002-8703, 11 p.Article

A novel experimental model of acute hypertriglyceridemia induced by schisandrin BPAN, Si-Yuan; HANG DONG; HAN, Yi-Fan et al.European journal of pharmacology. 2006, Vol 537, Num 1-3, pp 200-204, issn 0014-2999, 5 p.Article

Clofibrate acutely reverses saline-induced endothelial dysfunction : Role of calcium-activated potassium channelsSANKARALINGAM, Sowndramalingam; DESAI, Kaushik M; WILSON, Thomas W et al.American journal of hypertension. 2006, Vol 19, Num 11, pp 1167-1173, issn 0895-7061, 7 p.Article

Separation of fibrate-type antihyperlipidemic drugs by capillary electrophoresis and their quantitation in pharmaceuticalsKOMSTA, Lukasz; MISZTAL, Genowefa; MAJCHRZAK, Ewa et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 2, pp 408-414, issn 0731-7085, 7 p.Article

The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease : A retrospective chart review involving up to 8 years of follow-upNICHOLS, Gregory A; KORO, Carol E; CHAN, Wiley et al.Clinical therapeutics. 2006, Vol 28, Num 2, pp 243-250, issn 0149-2918, 8 p.Article

Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutionsGRANERO, Gladys E; RAMACHANDRAN, Chandrasekharan; AMIDON, Gordon L et al.Drug development and industrial pharmacy. 2005, Vol 31, Num 9, pp 917-922, issn 0363-9045, 6 p.Article